open access
Vol 24, No 6 (2017)
Original articles — Interventional cardiology
Submitted: 2016-09-27
Accepted: 2017-01-05
Published online: 2017-02-15
Get Citation
Immediate and long-term outcomes of percutaneous transcatheter pulmonary valve implantation
, , , , , , , ,
open access
Vol 24, No 6 (2017)
Original articles — Interventional cardiology
Submitted: 2016-09-27
Accepted: 2017-01-05
Published online: 2017-02-15
Abstract
Background: Transcutaneous pulmonary valve replacement (TPVR) has become an alternative to heart surgery for patients after previous right ventricular outflow tract (RVOT) or pulmonary artery (PA) surgical interventions. The objective was to present immediate and long-term outcomes of trans¬cutaneous pulmonary valve replacement.
Methods: Between 06/2009 and 06/2016, 46 patients underwent TPVR. Initial diagnoses included tetralogy of Fallot, common arterial trunk, transposition of great arteries post Rastelli correction, left ventricle outflow obstruction after Ross operation, pulmonary atresia, and isolated dysplastic pulmonary valve stenosis. Thirty eight (78%) patients had previously implanted conduits in the pulmonary position, the rest had either RVOT patch reconstruction (n = 6; 13%) or biological valve implantation (n = 2; 4%). They presented primarily with pulmonary stenosis (n = 18; 39%) or regurgitation (n = 28; 60%).
Results: All procedures were successful — 44 Melody and 2 Edwards-Sapien valves were implanted. Before each procedure exclusion of potential coronary compression and RVOT prestenting was performed. Significant RVOT systolic gradient reduction (from 35.3 ± 19.5 to 13.5 ± 7.1 mm Hg; p < 0.001) and decrease of right to left ventricle systolic pressure ratio from 0.58 ± 0.18 to mean 0.37 ± 0.1 (p < 0.001) was achieved. Also, in every patient PA-RVOT competence was restored, with minor in¬competence in only a few patients. Post procedure follow-up ranged from 2 to 86 (mean 35.2) months. Follow-up fluoroscopy or chest X-ray revealed 6 stent fractures (2 stent defragmentation — with only 1 significant valve stenosis).
Conclusions: Transcutaneous pulmonary valve replacement is a safe procedure with encouraging results, it also enables deferring surgical reintervention in the majority of patients.
Abstract
Background: Transcutaneous pulmonary valve replacement (TPVR) has become an alternative to heart surgery for patients after previous right ventricular outflow tract (RVOT) or pulmonary artery (PA) surgical interventions. The objective was to present immediate and long-term outcomes of trans¬cutaneous pulmonary valve replacement.
Methods: Between 06/2009 and 06/2016, 46 patients underwent TPVR. Initial diagnoses included tetralogy of Fallot, common arterial trunk, transposition of great arteries post Rastelli correction, left ventricle outflow obstruction after Ross operation, pulmonary atresia, and isolated dysplastic pulmonary valve stenosis. Thirty eight (78%) patients had previously implanted conduits in the pulmonary position, the rest had either RVOT patch reconstruction (n = 6; 13%) or biological valve implantation (n = 2; 4%). They presented primarily with pulmonary stenosis (n = 18; 39%) or regurgitation (n = 28; 60%).
Results: All procedures were successful — 44 Melody and 2 Edwards-Sapien valves were implanted. Before each procedure exclusion of potential coronary compression and RVOT prestenting was performed. Significant RVOT systolic gradient reduction (from 35.3 ± 19.5 to 13.5 ± 7.1 mm Hg; p < 0.001) and decrease of right to left ventricle systolic pressure ratio from 0.58 ± 0.18 to mean 0.37 ± 0.1 (p < 0.001) was achieved. Also, in every patient PA-RVOT competence was restored, with minor in¬competence in only a few patients. Post procedure follow-up ranged from 2 to 86 (mean 35.2) months. Follow-up fluoroscopy or chest X-ray revealed 6 stent fractures (2 stent defragmentation — with only 1 significant valve stenosis).
Conclusions: Transcutaneous pulmonary valve replacement is a safe procedure with encouraging results, it also enables deferring surgical reintervention in the majority of patients.
Get Citation
Keywords
pulmonary valve, transcatheter valve implantation, congenital heart disease
About this articleTitle
Immediate and long-term outcomes of percutaneous transcatheter pulmonary valve implantation
Journal
Issue
Pages
604-611
Published online
2017-02-15
Page views
2226
Article views/downloads
2280
DOI
Pubmed
Bibliographic record
Cardiol J 2017;24(6):604-611.
Keywords
pulmonary valve
transcatheter valve implantation
congenital heart disease
Authors
Roland Fiszer
Paweł Dryżek
Małgorzata Szkutnik
Sebastian Góreczny
Alexandra Krawczuk
Jadwiga Moll
Tomasz Moszura
Szymon Pawlak
Jacek Białkowski
References (26)- Davlouros PA, Karatza AA, Gatzoulis MA, et al. Timing and type of surgery for severe pulmonary regurgitation after repair of tetralogy of Fallot. Int J Cardiol. 2004; 97 Suppl 1: 91–101.
- Bonhoeffer P, Boudjemline Y, Qureshi SA, et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol. 2002; 39(10): 1664–1669.
- Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007; 116(5): 545–551.
- Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000; 356(9239): 1403–1405.
- Godart F, Baruteau AE, Petit J, et al. Transcatheter tricuspid valve implantation: a multicentre French study. Arch Cardiovasc Dis. 2014; 107(11): 583–591.
- Cullen MW, Cabalka AK, Alli OO, et al. Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. JACC Cardiovasc Interv. 2013; 6(6): 598–605.
- Hascoët S, Acar P, Boudjemline Y. Transcatheter pulmonary valvulation: current indications and available devices. Arch Cardiovasc Dis. 2014; 107(11): 625–634.
- Suradi HS, Hijazi ZM. Percutaneous pulmonary valve implantation. Glob Cardiol Sci Pract. 2015; 2015(2): 23.
- Ruzyłło W, Demkow M, Włodarska EK, et al. [POL-PAVTI--Polish report on transcatheter pulmonary artery valve implantation of Melody-Medtronic prosthesis in the first 14 patients in Poland]. Kardiol Pol. 2009; 67(10): 1155–1161.
- Armstrong AK, Balzer DT, Cabalka AK, et al. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study. JACC Cardiovasc Interv. 2014; 7(11): 1254–1262.
- Shimazaki Y, Blackstone EH, Kirklin JW. The natural history of isolated congenital pulmonary valve incompetence: surgical implications. Thorac Cardiovasc Surg. 1984; 32(4): 257–259.
- Davlouros PA, Karatza AA, Gatzoulis MA, et al. Timing and type of surgery for severe pulmonary regurgitation after repair of tetralogy of Fallot. Int J Cardiol. 2004; 97 Suppl 1: 91–101.
- Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005; 112(8): 1189–1197.
- Nordmeyer J, Coats L, Bonhoeffer P. Current experience with percutaneous pulmonary valve implantation. Semin Thorac Cardiovasc Surg. 2006; 18(2): 122–125.
- Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008; 117(15): 1964–1972.
- Sridharan S, Coats L, Khambadkone S, et al. Images in cardiovascular medicine. Transcatheter right ventricular outflow tract intervention: the risk to the coronary circulation. Circulation. 2006; 113(25): e934–e935.
- Butera G, Milanesi O, Spadoni I, et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Catheter Cardiovasc Interv. 2013; 81(2): 310–316.
- Morray BH, McElhinney DB, Cheatham JP, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013; 6(5): 535–542.
- Cardoso R, Ansari M, Garcia D, et al. Prestenting for prevention of melody valve stent fractures: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016; 87(3): 534–539.
- Cosentino D, Quail MA, Pennati G, et al. Geometrical and stress analysis of factors associated with stent fracture after melody percutaneous pulmonary valve implantation. Circ Cardiovasc Interv. 2014; 7(4): 510–517.
- Boshoff DE, Cools BLM, Heying R, et al. Off-label use of percutaneous pulmonary valved stents in the right ventricular outflow tract: time to rewrite the label? Catheter Cardiovasc Interv. 2013; 81(6): 987–995.
- Chessa M, Butera G, Giugno L, et al. Percutaneous pulmonary valve implantation in a single artery branch: A preliminary experience. World J Cardiol. 2015; 7(10): 695–699.
- Patel M, Malekzadeh-Milani S, Ladouceur M, et al. Percutaneous pulmonary valve endocarditis: incidence, prevention and management. Arch Cardiovasc Dis. 2014; 107(11): 615–624.
- Van Dijck I, Budts W, Cools B, et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart. 2015; 101(10): 788–793.
- Buber J, Bergersen L, Lock JE, et al. Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv. 2013; 6(3): 301–310.
- Gillespie MJ, Rome JJ, Levi DS, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012; 5(6): 862–870.
